Fax: (011) + 358-8-315 5559
Original Article
You have full text access to this OnlineOpen article
Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia
Article first published online: 25 APR 2002
DOI: 10.1002/cncr.10503
Copyright © 2002 American Cancer Society
Additional Information
How to Cite
Lehtinen, S. S., Huuskonen, U. E., Harila-Saari, A. H., Tolonen, U., Vainionpää, L. K. and Lanning, B. M. (2002), Motor nervous system impairment persists in long-term survivors of childhood acute lymphoblastic leukemia. Cancer, 94: 2466–2473. doi: 10.1002/cncr.10503
- †
Fax: (011) + 358-8-315 5559
Publication History
- Issue published online: 25 APR 2002
- Article first published online: 25 APR 2002
- Manuscript Accepted: 20 DEC 2001
- Manuscript Revised: 18 DEC 2001
- Manuscript Received: 17 SEP 2001
Funded by
- Alma och K. A. Snellman Foundation
- Nona and Kullervo Väre Foundation, Helsinki, Finland
REFERENCES
- 1. Neurotoxicity due to central nervous system therapy for childhood leukemia. Am J Pediatr Hematol Oncol. 1989; 11: 93–105.
- 2, , , , , . Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies. Radiology. 1991; 180: 205–209.
- 3, , , , . White matter changes in children treated for acute lymphoblastic leukemia. Cancer. 1992; 70: 2728–2733.
- 4, , , et al. Excessive spinal cord toxicity from intensive central nervous system-directed therapies. Cancer. 1994; 74: 3034–3041.
- 5, , , . Vincristine neuropathy. Clinical and electrophysiological observations. Brain. 1973; 96: 69–86.
- 6, , , , . Nerve lesions after therapy for childhood acute lymphoblastic leukemia. Cancer. 1998; 82: 200–207.
- 7, , . Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology. 1969; 19: 367–374.
- 8, , , . Vincristine therapy for children with acute lymphoblastic leukemia impairs conduction in the entire peripheral nerve. Pediatr Neurol. 1995; 13: 314–318.
- 9, , , et al. Fine motor and handwriting problems after treatment for childhood acute lymphoblastic leukemia. Med Pediatr Oncol. 1996; 27: 551–555.
- 10. Clinical neurological findings of children with acute lymphoblastic leukaemia at diagnosis and during treatment. Eur J Pediatr. 1993; 152: 115–119.
- 11, , , , . Motor nervous pathway function is impaired after treatment of childhood acute lymphoblastic leukemia: a study with motor evoked potentials. Med Pediatr Oncol. 2001; 36: 345–351.
- 12, , , et al. A population-based study of childhood acute lymphoblastic leukemia diagnosed from July 1981 through June 1985 in the five Nordic countries. Incidence, patient characteristics and treatment results. Acta Paediatr Scand. 1987; 76: 781–788.
- 13, , , et al. A population-based study of children with standard risk acute lymphoblastic leukemia in the five Nordic countries. A follow-up of 230 patients. Acta Paediatr Scand. 1989; 78: 104–109.
- 14, , , et al. [Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)]. Klin Padiatr. 1987; 199: 151–160.
- 15. Examination of the child with minor neurological dysfunction. Clinics in developmental medicine. No 71. 2nd edition. London: Heinemann Medical, 1979.
- 16, , . Cervical magnetic stimulation in children and adolescents: normal values and evaluation of the proximal lesion of the peripheral motor nerve in cases with polyradiculoneuropathy. Electroencephalogr Clin Neurophysiol. 1994; 93: 318–323.
- 17, , , et al. The diagnostic value of motor evoked potentials. Clin Neurophysiol. 1999; 110: 1297–1307.
- 18, , . Neurotoxicology of vincristine in the cat. Morphological study. Arch Toxicol. 1983; 52: 83–90.
- 19, , , . Chemotherapy for acute lymphoblastic leukemia may cause subtle changes of the spinal cord detectable by somatosensory evoked potentials. Med Pediatr Oncol. 1997; 28: 41–47.
- 20, , , et al. Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer. 1992; 70: 1997–2004.
- 21, . Leukoencephalopathy after chemotherapy and/or radiotherapy. In: Magnetic resonance of myelin, myelination and myelin disorders. 2nd edition. Heidelberg: Springer-Verlag, 1995: 10–11, 408.
- 22, , , , , . White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: correlation with neuropsychological findings. Med Pediatr Oncol. 2000; 35: 456–461.
- 23, , , et al. Abnormal visual-evoked potentials in leukemic children after cranial radiation. Med Pediatr Oncol. 1985; 13: 313–317.
- 24, . Some aspects of neurotoxicity associated with central nervous system prophylaxis in childhood leukemia. Acta Haematol. 1987; 78( Suppl 1): 139–141.
- 25, , , , , . Magnetic resonance imaging and magnetic resonance angiography in long term survivors of acute lymphoblastic leukemia treated with cranial irradiation. Cancer. 1995; 76: 1846–1852.
- 26, , , et al. Comparison of neuropsychologic functioning and clinical indicators of neurotoxicity on long-term survivors of childhood leukemia given cranial radiation or parental methotrexate: a prospective study. J Clin Oncol. 1991; 9: 145–151.
- 27, , , , , . Chemotherapy for acute lymphocytic leukemia: cognitive and academic sequelae. J Pediatr. 1992; 121: 885–889.
- 28
- 29, , , , , . Variability in the amplitude of skeletal muscle responses to magnetic stimulation of the motor cortex in man. Electroencephalogr Clin Neurophysiol. 1998; 109: 104–113.

1097-0142/asset/olbannerleft.gif?v=1&s=ca681f5719430b26e1bc15e9ea4c9fc0a7110104)
1097-0142/asset/olbannerright.gif?v=1&s=8142566facf7e76aef9be6c51162a2e920b3b9f9)
1097-0142/asset/cover.gif?v=1&s=a7299bc18f075294c232ade468773cd0672bd470)